top of page

Johnson & Johnson Covid-19 Vaccine: Europeans & US Monitoring Flag SEVERE Safety Issues, Deaths

This is part three of a three series safety review of all currently approved US Covid-19 Emergency Use Only vaccinations (Part 1- Pfizer HERE - Part 2- Moderna Here) - Full outline of all Covid-19 safety, efficacy, and concerns HERE)

Note: 1976, the Swine Vaccination program was halted in 9 U.S. states after three deaths were suspected to be associated with the vaccines and the entire program was halted shortly thereafter.

In 2021, 3,848 deaths have been reported post Covid-19, over 750 within minutes to hours with listed side effects of the vaccinations. CDC denies any correlation to vaccination, even in cases of anaphylactic shock.

Johnson & Johnson Janessen Covid-19 Vaccine Resumes After 154 Post Vaccine Deaths, 40 Occurred within 24 Hours - European investigation finds a possible direct link to drug and blood clotting injuries (Moderna & Pfizer have present with the same issues). Public health official and media trial claims of vaccine benefit outweighing risk are not supported by trial and government data evidence. Substantive evidence does not document decrease in severe outcome with administration of J&J vaccinations

Stanford University latest study of Covid-19 infection morbidity rate of .15% (99.85 survival rate) much lower than previously estimated. Lethality lower than other seasonal respiratory illness. Oxford study shows estimated 86.5 of individuals will express no core symptoms of Covid-19 infection (research shows flawed testing cycle rate recommendations causing up to 90% false positives, non-symptomatic presentation very likely due to testing flaws not asymptomatic transmission explained HERE). Covid-19 has very low lethality rate for the general population with majority of population expressing no symptoms with a positive PCR diagnosis for Covid-19.

-"The Janssen COVID‑19 Vaccine is for active immunization to prevent COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older. The vaccine contains a recombinant, replication-incompetent human adenovirus serotype 26 (Ad26) vector, encoding the SARS-CoV-2 viral spike (S) glycoprotein, stabilized in its pre-fusion form. It is an investigational vaccine not licensed for any indication" Direct quote from emergency approval letter issued on 2/27/2021

-Johnson & Johnson Covid-19 Covid-19 are administered for symptom suppression of Covid-19 infections, with a 66% effectiveness rate for this purpose, vaccine was trialed for majority mild cases and trials did NOT measure for decrease in severe outcomes (decrease in death and hospitalization) nor reduction of transmission of disease or immunity properties. Vaccine offers no improvement in the above study numbers. No substantive benefit for Johnson & Johnson vaccination has been documented in trial evidence over above Covid-19 symptom and morbidity rate numbers.

-Johnson & Johnson was paused for concern over blood clots and resumed on the same day a Oregon woman died of blood clotting issues post J&J vaccination and while investigation is still ongoing..

-Blood clots are far from the only safety issue associated with Johnson & Johnson Covid-19 vaccinations with several mass clinics shutting down across the country only days before the CDC vaccine pause due to widespread serious reactions and hospitalizations required after administration of the vaccine

-Johnson & Johnson manufacturing plant (sub-contractor Emergent Biosolutions) responsible for producing active ingredient for Covid-19 vaccination shut down by FDA after contaminating up to 62 million doses of J & J vaccine with AstraZeneca active ingredient components AstraZeneca Covid-19 vaccine in United States and has been halted in numerous countries due to severe blood clotting issues (Emergent Biotech produces active ingredients for both manufacturers, both companies utilize controversial adenovirus technology never approved before for human use outside military applications.

-European researchers have found a possible direct correlation between Johnson & Johnson vaccinations and the blood clotting issues - this coincides with researchers in Norway finding a link between blood clots and the AstraZeneca vaccinations - both drugs utilizing the same adenovirus technology

-CDC appears to have adopted a 'plausible deniability' standard for attributing post vaccination deaths to Covid-19 vaccinations. The agency dismisses deaths occurring within minutes of vaccine administration with symptoms matching listed FDA side effects for Covid-19 vaccines, as unrelated to vaccines. Often, no autopsies are performed and there is no set standard for post Covid-19 vaccination postmortem review.

-United States Covid-19 mass vaccination program launched without appropriate monitoring system in place, with VAERS CDC system estimated to capture only 1% of vaccine injuries/deaths. according to Harvard Study. (Data is credible as far as it goes, with 83% generated from medical providers, state reporting agencies, and pharmaceutical agencies).

Johnson & Johnson Janssen Covid-19 Vaccination: Safety Risks by the Numbers:

Vaers Data Reports as of April 20, 2021 (Book mark this post for weekly updates of numbers)

Total adverse events recorded:


Total deaths: 154 events

20 deaths within minutes to hours of vaccination

20 deaths occurred within one day post vaccine

12 within two days post vaccination

12 within three days post vaccination

Life threatening Events: 168

Hospitalizations: 458

Emergency Room Visits: 1,174

European Monitoring Johnson & Johnson Adverse Events

Total reactions for the experimental COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 19 deaths and 246 injuries to 17/04/2021

(No graph yet)

  • 9 Blood and lymphatic system disorders incl. 1 death

  • 29 Cardiac disorders incl. 5 deaths

  • 1 Congenital, familial and genetic disorder

  • 16 Ear and labyrinth disorders

  • 1 Endocrine disorder

  • 14 Eye disorders

  • 61 Gastrointestinal disorders

  • 154 General disorders and administration site conditions incl. 8 deaths

  • 4 Hepatobiliary disorders

  • 10 Immune system disorders

  • 27 Infections and infestations

  • 16 Injury, poisoning and procedural complications

  • 40 Investigations

  • 12 Metabolism and nutrition disorders

  • 59 Musculoskeletal and connective tissue disorders

  • 0 Neoplasms benign, malignant and unspecified (incl cysts and polyps)

  • 138 Nervous system disorders incl. 1 death

  • 0 Pregnancy, puerperium and perinatal conditions

  • 1 Product issue

  • 24 Psychiatric disorders

  • 9 Renal and urinary disorders incl. 1 death

  • 4 Reproductive system and breast disorders

  • 49 Respiratory, thoracic and mediastinal disorders incl. 1 death

  • 28 Skin and subcutaneous tissue disorders

  • 4 Social circumstances

  • 4 Surgical and medical procedures

  • 44 Vascular disorders incl. 2 deaths

Johnson & Johnson Janssen Covid-19 Vaccine Safety/In the News

Health officials are utilizing the same plausible deniability standard the CDC has employed for all 3,484 post to deny any connection between John Foley post vaccination death as correlated to the Johnson & Johnson vaccine. No investigation is complete, yet the coroner came out and stated 'no evidence' which prompted media outlets to incorrectly declare events were unrelated.

John Francis Foley, Medical Student

Many health care professionals are deeply concerned about Covid-19 vaccine safety, please go here to review full evidence, documentation on Covid-19 safety and efficacy issues (compiled by health care professionals):

VAERS CDC Data Search

Screenshot for 20 cases of deaths occurring 1 day post Johsnon & Johson Covid-19 vaccination. Go to to plug in VAERS ID number and review each case:

Screen shot of Deaths Occurring within minutes to hours of vaccine:

(note some deaths generate multiple reports from different entities) - 20 deaths total)

Sixty one year old South Carolina woman developed cerebral hemorrhage post Covid-19 vaccination and died the same day:


bottom of page